Clinical Trial Update: Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)

View source ↗

Summary

Merck-sponsored trial MK-0431-401 evaluated the incidence of hypoglycemic events in participants with Type 2 Diabetes Mellitus; results were posted on 2014-03-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0431-401 (MK-0431)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2014-03-24